518 related articles for article (PubMed ID: 31543684)
1. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
Janka T; Tornai T; Borbély B; Tornai D; Altorjay I; Papp M; Vitális Z
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):257-264. PubMed ID: 31464790
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
Wong ZY; Koh JH; Muthiah M; Koh B; Ong EYH; Ong CEY; Ou KQ; Lim WH; Tan DJH; Chee D; Siah KTH; Wong Y; Kaewdech A; Wijarnpreecha K; Kulkarni AV; Nah B; Huang DQ; Noureddin M; Ng CH; Teng M
Dig Dis Sci; 2024 Jan; 69(1):289-297. PubMed ID: 37968557
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.
Tergast TL; Wranke A; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
Liver Int; 2018 Sep; 38(9):1602-1613. PubMed ID: 29675988
[TBL] [Abstract][Full Text] [Related]
9. Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
Low EXS; Wang YP; Lu CL
Dig Dis Sci; 2024 Jan; 69(1):7-9. PubMed ID: 37968555
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure.
Zhang M; Xu X; Liu W; Zhang Z; Cheng Q; Yang Z; Liu T; Liu Y; Ning Q; Chen T; Qi J
Adv Ther; 2021 Sep; 38(9):4675-4694. PubMed ID: 34308513
[TBL] [Abstract][Full Text] [Related]
11. Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites.
Dam G; Vilstrup H; Andersen PK; Bossen L; Watson H; Jepsen P
Liver Int; 2019 Mar; 39(3):514-521. PubMed ID: 30472808
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Dam G; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis.
Dultz G; Piiper A; Zeuzem S; Kronenberger B; Waidmann O
Aliment Pharmacol Ther; 2015 Mar; 41(5):459-66. PubMed ID: 25523381
[TBL] [Abstract][Full Text] [Related]
15. High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
Yoon JS; Hong JH; Park SY; Kim SU; Kim HY; Kim JY; Hur MH; Park MK; Lee YB; Lee HA; Kim GA; Sinn DH; Park SJ; Lee YJ; Kim YJ; Yoon JH; Lee JH
Aliment Pharmacol Ther; 2024 Apr; 59(8):973-983. PubMed ID: 38389319
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
[TBL] [Abstract][Full Text] [Related]
17. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
Hung TH; Lee HF; Tseng CW; Tsai CC; Tsai CC
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):353-359. PubMed ID: 29551615
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
[TBL] [Abstract][Full Text] [Related]
20. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
